Erratum: Activation of the Connective Tissue Growth Factor (CTGF)-Transforming Growth Factor β 1 (TGF-β 1) Axis in Hepatitis C Virus-Expressing Hepatocytes (PLoS ONE (2012) 7:10 (e46526) DOI: 10.1371/journal.pone.0046526);Activation of the Connective Tissue Growth Factor (CTGF)-Transforming Growth Factor β 1 (TGF-β 1) Axis in Hepatitis C Virus-Expressing Hepatocytes

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Nagaraja, Tirumuru ^a   Chen, Li ^b   Balasubramanian, Anuradha ^c   Groopman, Jerome E ^c   Ghoshal, Kalpana ^d   Jacob, Samson T ^d   Leask, Andrew ^e   Brigstock, David R ^b   Anand, Appakkudal R ^a   Ganju, Ramesh K ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; CONNECTIVE TISSUE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; SHORT HAIRPIN RNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE SILENCING; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TECHNIQUE; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; PATHOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPLICON; VIRUS EXPRESSION; WESTERN BLOTTING;

HEPATITIS C VIRUS;

EID: 84867121831     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0290786     Document Type: Erratum

References (36)

1. Zoulim F, Chevallier M, Maynard M, Trepo C, (2003) Clinical consequences of hepatitis C virus infection. Rev Med Virol 13: 57-68.
2. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S, (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7: d793-807.
3. Rachfal AW, Brigstock DR, (2003) Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 26: 1-9.
4. Brigstock DR, (2002) Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 5: 153-165.
5. Gao R, Brigstock DR, (2006) A novel integrin alpha5beta1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells. Gut 55: 856-862.
6. Ponticos M, Holmes AM, Shi-wen X, Leoni P, Khan K, et al. (2009) Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum 60: 2142-2155.
7. Surveyor GA, Brigstock DR, (1999) Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation. Growth Factors 17: 115-124.
8. Brigstock DR, (1999) The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20: 189-206.
9. Zhao Z, Ho L, Wang J, Qin W, Festa ED, et al. (2005) Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology. FASEB J 19: 2081-2082.
10. Grotendorst GR, Okochi H, Hayashi N, (1996) A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7: 469-480.
11. Hora C, Negro F, Leandro G, Oneta CM, Rubbia-Brandt L, et al. (2008) Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C. Liver Int 28: 370-376.
12. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, et al. (1999) Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30: 968-976.
13. Shin JY, Hur W, Wang JS, Jang JW, Kim CW, et al. (2005) HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med 37: 138-145.
14. Tong Z, Chen R, Alt DS, Kemper S, Perbal B, et al. (2009) Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology 50: 939-947.
15. Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, et al. (2009) Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat 16: 612-620.
16. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, et al. (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337-23347.
17. Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, et al. (2008) Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135: 642-659.
18. Nitta T, Kim JS, Mohuczy D, Behrns KE, (2008) Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology 48: 909-919.
19. Dong ZZ, Yao DF, Yao M, Qiu LW, Zong L, et al. (2008) Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 7: 288-295.
20. Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, et al. (1997) Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat 4: 29-35.
21. Blight KJ, McKeating JA, Rice CM, (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014.
22. Chen L, Charrier AL, Leask A, French SW, Brigstock DR, (2010) Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor. J Hepatol.
23. Charrier AL, Brigstock DR, (2010) Connective tissue growth factor production by activated pancreatic stellate cells in mouse alcoholic chronic pancreatitis. Lab Invest 90: 1179-1188.
24. Gressner OA, Lahme B, Demirci I, Gressner AM, Weiskirchen R, (2007) Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 47: 699-710.
25. Leask A, Sa S, Holmes A, Shiwen X, Black CM, et al. (2001) The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol 54: 180-183.
26. Shi-wen X, Kennedy L, Renzoni EA, Bou-Gharios G, du Bois RM, et al. (2007) Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum 56: 4189-4194.
27. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
28. Hall CH, Kassel R, Tacke RS, Hahn YS, (2010) HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta. PLoS One 5: e12154.
29. Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA, (2008) Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 48: 1420-1429.
30. Blight KJ, Norgard EA (2006) HCV Replicon Systems.
31. Gore-Hyer E, Shegogue D, Markiewicz M, Lo S, Hazen-Martin D, et al. (2002) TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 283: F707-716.
32. Lin W, Wu G, Li S, Weinberg EM, Kumthip K, et al. (2011) HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB. J Biol Chem 286: 2665-2674.
33. Presser LD, Haskett A, Waris G, (2011) Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-beta1: role of TGF-beta1 in HCV replication. Virology 412: 284-296.
34. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, et al. (2002) CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 62: 1149-1159.
35. Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, et al. (2007) Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 293: G1147-1154.
36. Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, et al. (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15: 1430-1440.